Q3 2012 Results (all percentages are to comparable periods in 2011) Q3 2012 reported sales increased 2% to $639 million. Sales grew organically by 2% with Research and Sigma-Aldrich Fine Chemicals (“SAFC”) organic sales growth of 1% and 5%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency exchange rates reduced otherwise reportable […]
Minneapolis — Techne Corporation’s (NASDAQ:TECH) financial results for the quarter ended September 30, 2012 include the following highlights: – First quarter earnings were $25.7 million or $.70 per diluted share. Adjusted earnings for the quarter were $27.5 million (a decrease of 8.2% from the prior fiscal year period) or $.75 per diluted share. Earnings and […]
MILFORD, Mass.—- Waters Corporation (NYSE: WAT) reported today third quarter 2012 sales of $450 million, a 1% decrease in comparison to sales of $455 million in the third quarter of 2011. For the quarter, foreign currency translation reduced sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the third quarter […]
Cambridge, Massachusetts (United States) – Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), announces that it has been awarded a second contract to provide services to the National Institutes of Health (NIH) and certain other government agencies. This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract, has a maximum order […]
LAKE FOREST, Ill– IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended September 30, 2012. New orders in the quarter totaled $464 million, down 3 percent from the prior year period. Sales in the quarter totaled $480 million, 1 percent higher than the prior year period. For the quarter, on […]
Indianapolis, IN — BioCrossroads announced today the finalists in a new competition to spur Indiana’s innovation economy. To accelerate entrepreneurial activity and encourage the development of early-stage Indiana life sciences companies, BioCrossroads launched the New Venture Competition, presented by the law firm Krieg DeVault, earlier this year. Altogether, eight companies qualified as finalists, out of […]
Cambridge, Massachusetts (United States) – Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), announces that it has been awarded a contract to provide services to the National Institutes of Health (NIH) and certain other government agencies. This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract, has a maximum order limit […]
WATERLOO, Ontario, — P&P Optica Inc., a world leader in the design, development and manufacturing of high performance optical spectrometers, has been granted a fund of $985,000 through the Federal Economic Development Agency’s Investing in Business Innovation program. The Government of Canada investment was announced today at P&P Optica Inc. by Peter Braid, Member of […]
BERGISCH GLADBACH, Germany — RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies, Inc. (BEST), today announced the award of a contract for five radio frequency (rf) cavities for the Facility for Antiproton and Ion Research (FAIR) project, valued at approximately $5.8 million. The contract includes design and construction of rf […]
SEATTLE, WA—(Marketwire – Stratos Genomics Inc today announced the closing of $2 million to support continued development and strategic discussions related to Stratos’ ultra low cost method of DNA sequencing called “Sequencing by Expansion™” (SBX™). The funding follows the successful demonstration of single molecule DNA sequencing of 36 base templates by SBX this past June. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
